Drug treatment to reduce cholesterol to new target levels is now recommended in four moderate- to high-risk patient populations: patients who have already sustained a cardiovascular event, adult ...
This electronic resource aims to provide physicians with fast and easy access to practical guidelines linked to the best available research evidence. It covers a wide range of medical conditions and ...
1 Department of Clinical Epidemiology, Biostatistics and Bioinformatics (KEBB), Academic Medical Centre (AMC), University of Amsterdam (UvA), Amsterdam, The Netherlands 2 Dutch Cochrane Centre (DCC), ...
Correspondence to Dr Veronika Williams, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK; veronika.williams{at}phc.ox.ac.uk Given its scope and its place ...
Associate Editor, Evidence Based Medicine, Department of Family Medicine, University of Alberta, Canada Correspondence to Denise Campbell-Scherer Associate Professor, Department of Family Medicine, ...
Correspondence to Sir Iain Chalmers, James Lind Initiative, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK; ichalmers{at}jameslind.net We are surrounded by maelstroms of claims about the effects ...
Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...
Correspondence to Dr Zachary Munn, JBI, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia; zachary.munn{at}adelaide.edu.au We are concerned about ...
A network meta-analysis combines the evidence from existing randomised trials about the comparative efficacy of multiple treatments. It allows direct and indirect evidence about each comparison to be ...
Correspondence to Dr Gillian Stokes, Social Research Institute, EPPI Centre, University College London, London, WC1H 0NS, UK; gillian.stokes{at}ucl.ac.uk Searches conducted a year or more before ...